Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla

October 18, 2019 updated by: Yanglin Pan, Air Force Military Medical University, China

Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla: a Randomized Non-inferiority Trial

Examination of major duodenal papilla (MDP) using a side-viewing duodenoscope is a golden standard. However, side-viewing duodenoscope is not available in some endoscopic centers. Cap-assisted esophagogastroduodenoscopy (Ca-EGD) using a transparent cap fitted to the tip of the scope has emerged as an alternative method for the observation of MDP. A recent study showed that complete examination of MDP could be achieved in 97% of patients. The investigators hypothesize that Ca-EGD is non-inferior to duodenoscope for the observation of MDP.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Interim analyses were planned to be performed by the data and safety monitoring board after data collection has been completed for 50% of the enrollment.

Study Type

Interventional

Enrollment (Actual)

171

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chongqing, China, 400010
        • Department of gastroenterology, Second Affiliated Hospital of Chongqing Medical University
    • Shaanxi
      • Xi'an, Shaanxi, China, 710032
        • Endoscopic center, Xijing Hospital of Digestive Diseases

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age > 18 years and < 70 years
  • Patients with native MDP who underwent ERCP

Exclusion Criteria:

  • Prior surgery in upper GI tract
  • Prior history of endoscopic sphincterotomy
  • Prior history of MDP treatment
  • Known or suspected obstruction of upper GI tract
  • Patients in poor condition who may not be suitable for Ca-EGD or duodenoscope
  • Pregnancy or lactic women
  • Inability to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cap group: Cap-EGD
Undergoing cap-assisted esophagogastroduodenoscopy
Undergoing cap-assisted endoscopy
Active Comparator: Duo group: Duo
Undergoing side-viewing duodenoscope
Undergoing side-viewing duodenoscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of complete examination of MDP
Time Frame: 5 minutes after intubation of the esophagus
Complete examination is defined by visualization of both proximal and distal ends with orifice of papilla
5 minutes after intubation of the esophagus

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endoscopic findings in descending duodenum
Time Frame: 5 minutes after intubation of the esophagus
All pathological findings which are seen in descending duodenum should be reported (e.g. ampullary adenoma, peripapillary diverticulum, ampullary carcinoma, inflammatory change of papilla, etc)
5 minutes after intubation of the esophagus
Overall endoscopic findings
Time Frame: 5 minutes after intubation of the esophagus
All pathological findings which are seen during the examination should be reported (e.g. reflux esophagitis, gastric cancer, gastric ulcer, duodenal ulcer, etc)
5 minutes after intubation of the esophagus
MDP examination time
Time Frame: 5 minutes after intubation of the esophagus
The times taken for the examination of the MDP (after passing the pylorus until examination of MDP)
5 minutes after intubation of the esophagus
MDP examination score
Time Frame: 5 minutes after intubation of the esophagus
Score 3 when proximal end, distal end and orifice were visualized; Score 2 when either proximal or distal end with orifice were visualized; Score 1 when either proximal or distal end without orifice was visualized; Score 0 when the MDP could not be localized
5 minutes after intubation of the esophagus

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2018

Primary Completion (Actual)

July 20, 2018

Study Completion (Actual)

July 20, 2018

Study Registration Dates

First Submitted

July 13, 2017

First Submitted That Met QC Criteria

July 13, 2017

First Posted (Actual)

July 17, 2017

Study Record Updates

Last Update Posted (Actual)

October 22, 2019

Last Update Submitted That Met QC Criteria

October 18, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • KY20170517-3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Observation of Major Duodenal Papilla (MDP)

Clinical Trials on Cap-EGD

Subscribe